Topical NSAID formulations

Pain Medicine (United States)

Volumn 14, Issue SUPPL1, 2013, Pages

  Mcpherson, Mary Lynn ^a   Cimino, Nina M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Nonsteroidal Anti Inflammatory Drug; Osteoarthritis; Topical

Indexed keywords

DICLOFENAC; DICLOFENAC EPOLAMINE; DIMETHYL SULFOXIDE; FLECTOR PATCH; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SALICYLIC ACID METHYL ESTER; UNCLASSIFIED DRUG; WARFARIN;

ANEMIA; ARTHRALGIA; ARTICLE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUCED HEADACHE; DRUG PENETRATION; DRUG SAFETY; DRUG SOLUBILITY; DRUG WITHDRAWAL; DRY SKIN; ERYTHEMA; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTRANSAMINASEMIA; META ANALYSIS; MOLECULAR WEIGHT; MUSCULOSKELETAL PAIN; NEPHROTOXICITY; NEUROPATHIC PAIN; OSTEOARTHRITIS; PARESTHESIA; PRACTICE GUIDELINE; PRURITUS; SKIN IRRITATION; SKIN PERMEABILITY; UNITED STATES;

NONSTEROIDAL ANTI-INFLAMMATORY DRUG; OSTEOARTHRITIS; TOPICAL;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; EVIDENCE-BASED MEDICINE; HUMANS;

EID: 84890889350     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12288     Document Type: Article

References (24)

1. The Topical/Transdermal Ad Hoc Advisory Panel for the USP Performance Tests of Topical and Transdermal Dosage Forms, Ueda CT, Shah VP, Derdzinski K, etal. Topical and transdermal drug products. Pharmacopeial Forum 2009;35(3):750-764.
2. Novartis. 2009. Voltaren Gel Prescribing Information. Available at: http://www.voltarengel.com/common/pdf/Voltaren-PI-10-19.pdf (accessed September 2013).
3. Mallinckrodt Brand Pharmaceuticals, Inc. 2010. Pennsaid Prescribing Information. Available at: http://www.pennsaid.com/files/PENNSAID_Prescribing_Information.pdf (accessed September 2013).
4. INST Biochem. 2011. Flector Prescribing Information. Available at: http://labeling.pfizer.com/ShowLabeling.aspx?id=829 (accessed September 2013).
5. Fougera Pharmaceuticals. 2011. Solaraze Gel Prescribing Information. https://www.solaraze.com/solaraze/pdf/solaraze_pi.pdf (accessed September 2013).
6. Stanos SP. Topical agents for the management of musculoskeletal pain. J Pain Symptom Manage 2007;33(3):342-355.
7. Herndon CM. Topical delivery of nonsteroidal anti-inflammatory drugs for osteoarthritis. J Pain Palliat Care Pharmacother 2012;26:18-23.
8. Makris UE, Kohler MJ, Fraenkel L. Adverse effects (AEs) of topical NSAIDs in older adults with osteoarthritis (OA): A systemic review of the literature. J Rheumatol 2010;73(6):1236-1243.
9. Lin J, Zhang W, Jones A, etal. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: Meta-analysis of randomized controlled trials. Br Med J 2004;329:324.
10. Roth SH, Fuller P. Pooled safety analysis of diclofenac sodium topical solution 1.5% (w/w) in the treatment of osteoarthritis in patients aged 75 years or older. Clin Interv Aging 2012;7:127-137.
11. Peniston JH, Gold MS, Wieman MS, etal. Long-term tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities. Clin Interv Aging 2012;7:517-523.
12. Stanos SP. Osteoarthritis guidelines: A progressive role for topical nonsteroidal anti-inflammatory drugs. J Multidiscip Healthc 2013;6:133-137.
13. Brown MB, Martin GP, Jones SA, etal. Dermal and transdermal drug delivery systems: Current and future prospects. Drug Deliv 2006;13(3):175-187.
14. de Leon-Casasola OA. Multimodal approaches to the management of neuropathic pain: The role of topical analgesia. J Pain Symptoms Manage 2007;33(3):356-364.
15. Mason L, Moore RA, Edwards JE, etal. Topical NSAIDs for chronic musculoskeletal pain: Systemic review and meta-analysis. BMC Musculoskelet Disord 2004;5:28.
16. Baraf HS, Gold MS, Clark MB, etal. Safety and efficacy of topical diclofenac sodium 1% gel in knee osteoarthritis: A randomized controlled trial. Phys Sportsmed 2010;38(2):19-28.
17. Barthel HR, Haselwood D, Longley S 3rd, etal. Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis. Semin Arthritis Rheum 2009;39(3):203-212.
18. Massey T, Derry S, Moore RA, McQuay HJ. Topical NSAIDs for acute pain in adults. Cochrane Database Syst Rev 2010;(6):CD007402, doi: 10.1002/14651858.CD007402.pub2.
19. Derry S, Moore RA, Rabbie R. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev 2012;(9):CD007400, doi: 10.1002/14651858.CD007400.pub2.
20. Brown GA. AAOS clinical practice guideline: Treatment of osteoarthritis of the knee: Evidence-based guideline. J Am Acad Orthop Surg 2013;21(9):577-579.
21. National Institute for Health and Clinical Excellence. NICE clinical guideline 59. The care and management of osteoarthritis in adults. 2008.
22. Hochberg MC, Altman RD, April KT, etal. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 2012;64(4):465-474.
23. Yip AS, Chow WH, Tai YT, etal. Adverse effect of topical methylsalicylate ointment on warfarin anticoagulation: An unrecognized potential hazard. Postgrad Med J 1990;66(775):367-369.
24. Chow WH, Cheung KL, Ling HM, etal. Potentiation of warfarin anticoagulation by topical methylsalicylate ointment. J R Soc Med 1989;82(8):501-502.